Topical application of sh-oligopeptide-1 and clinical trials with cosmetic preparations: risk or fraud?

References

• Martínez-Carpio PA. Epidermal growth factor forty years after its discovery: from biochemistry to clinical applications. Endocrinol Nutr. 2003;50(8):334–344. doi: 10.1016/S1575-0922(03)74547-1.
   Google Scholar
• Mur C, Martínez-Carpio PA, Fernández-Montolí ME, et al. Growth of MDA-MB-231 cell line: different effects of TGF-ß1, EGF and estradiol depending on the length of exposure. Cell Biol Int. 1998;22(9-10):679–684. doi: 10.1006/cbir.1998.0306.
   PubMed Web of Science ®Google Scholar
• Martínez-Carpio PA, Mur C, Rosel P, et al. Constitutive and regulated secretion of epidermal growth factor and transforming growth factor-ß1 in MDA-MB-231 cell line in 11-day cultures. Cell Signal. 1999;11(10):753–757. doi: 10.1016/s0898-6568(99)00048-0.
   PubMed Web of Science ®Google Scholar
• Martínez-Carpio PA, Mur C, Fernández-Montolí ME, et al. Secretion and dual regulation between epidermal growth factor and transforming growth factor-ß1 in MDA-MB-231 cell line in 42-hour-long cultures. Cancer Lett. 1999;147(1-2):25–29. doi: 10.1016/s0304-3835(99)00261-x.
   PubMed Web of Science ®Google Scholar
• Martínez-Carpio PA, Navarro MA. Growth factors, cell damage, cyclin-dependent kinases and their inhibitors: relevance in molecular pathology of human cancer. Med Clin. 2003;120(7):265–271. doi: 10.1016/s0025-7753(03)73673-2.
   PubMed Web of Science ®Google Scholar
• Martínez-Carpio PA, Trelles MA. The role of epidermal growth factor receptor in photodynamic therapy: a review of the literature and proposal for future investigations. Lasers Med Sci. 2010;25(6):767–771. doi: 10.1007/s10103-010-0790-0.
   PubMed Web of Science ®Google Scholar
• Martínez-Carpio PA, Trelles MA. Cutaneous epidermal growth factor receptor system following ultraviolet irradiation: exploring the roles of molecular mechanisms. Photodermatol Photoimmunol Photomedicine. 2010; 26:450–256.
   Web of Science ®Google Scholar
• Márquez EB, Ortueta DD, Royo SB, et al. Epidermal growth factor receptor in corneal damage: update and new insights of recent reports. Cutan Ocul Toxicol. 2011; 30:1–8.
   PubMed Web of Science ®Google Scholar
• Lou-Bonafonte JM, Bonafonte-Marquez E, Bonafonte-Royo S, et al. Posology, efficacy, and safety of epidermal growth factor eye drops in 305 patients: logistic regression and group-wise odds of published data. J Ocul Pharmacol Ther. 2012;28(5):467–472. doi: 10.1089/jop.2011.0236.
   PubMed Web of Science ®Google Scholar
• Weiss RA, Weiss MA. Evaluation of a novel anti-aging topical formulation containing cycloastragenol, growth factors, peptides, and antioxidants. J Drugs Dermatol. 2014;13(9):1135–1139.
   PubMed Web of Science ®Google Scholar
• Seral-Gajón AL, Carreras-Sospedra A, López-Jimeno C, et al. Therapy of secondary cutaneous toxicity as a result of radiotherapic treatment, with a sH-oligopeptide-1 cream based (epidermal growth factor-egf): a pilot study. Actual Med. 2018;103(804):76–81. doi: 10.15568/am.2018.804.or04.
   Google Scholar
• Salvador Ferreira M, Magalhaes MC, Sousa-Lobo JM, et al. Trending anti-Aging peptides. Cosmetics. 2020;7(4):91. doi: 10.3390/cosmetics7040091.
   Google Scholar
• Fisher N, Carati D. Application of synthetic peptides to improve parameters of skin physiology: an open observational 30-Day study. JCDSA. 2020;10(04):163–175. doi: 10.4236/jcdsa.2020.104018.
   Google Scholar
• Sadowski G, Sadowski J. Safety and efficacy of a novel antiaging skin care regimen containing neutraceuticals and growth factors on the facial skin of women: a 12-Week open-label study. J Clin Aesthet Dermatol. 2020;13(6):24–34.
   PubMedGoogle Scholar
• Wathoni N, Rusdiana T, Hasanah AN, et al. Epidermal growth factor in sacran hydrogel film accelerates fibroblast migration. J Adv Pharm Technol Res. 2020;11(2):74–80. doi: 10.4103/japtr.JAPTR_147_19.
   PubMed Web of Science ®Google Scholar
• Oliveira BC, de Oliveira BGRB, Deutsch G, et al. Effectiveness of a synthetic human recombinant epidermal growth factor in diabetic patients wound healing: Pilot, double-blind, randomized clinical controlled trial. Wound Repair Regen. 2021;29(6):920–926. doi: 10.1111/wrr.12969.
   PubMed Web of Science ®Google Scholar
• Skibska A, Perlikowska R. Signal Peptides - Promising ingredients in cosmetics. Curr Protein Pept Sci. 2021;22(10):716–728. doi: 10.2174/1389203722666210812121129.
   PubMed Web of Science ®Google Scholar
• Wattanakrai P, Sindhusen S, Ploydaeng M. Effectiveness of an epidermal growth factor-containing cream on postinflammatory hyperpigmentation after 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser treatment of acquired bilateral nevus of ota-like macules (hori’s nevus) in asians: a split-face, double-blinded, randomized controlled study. J Cosmet Dermatol. 2022;21(5):2031–2037. doi: 10.1111/jocd.14765.
   PubMed Web of Science ®Google Scholar
• Gentile P, Ki M-S. Hair growth booster effects of micro-needling with low-level LED therapy and growth factors on subjects treated with finasteride. Appl Sci. 2022; 12:2164.
   Google Scholar
• Gentile P. Preliminary investigation on micro-needling with low-level LED therapy and growth factors in hair loss related to COVID-19. JCM. 2022;11(19):5760. doi: 10.3390/jcm11195760.
   Google Scholar
• Gentile P, Garcovich S, Lee S-I, et al. Regenerative biotechnologies in plastic surgery: a multicentric, retrospective, case-series study on the use of micro-needling with low-level light/laser therapy as a hair boost in patients affected by androgenetic alopecia. Appl Sci. 2021;12(1):217. doi: 10.3390/app12010217.
   Google Scholar
• Ferrer Soler L, Cedano J, Querol E, et al. Cloning, expression and purification of human epidermal growth factor using different expression systems. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;788(1):113–123. doi: 10.1016/s1570-0232(02)01035-8.
   PubMed Web of Science ®Google Scholar
• Mas JM, Aloy P, Martí-Renom MA, et al. Protein similarities beyond disulphide bridge topology. J Mol Biol. 1998;284(3):541–548. doi: 10.1006/jmbi.1998.2194.
   PubMed Web of Science ®Google Scholar
• Panosa C, Tebar F, Ferrer-Batallé M, et al. Development of an epidermal growth factor derivative with EGFR blocking activity. PLoS One. 2013;8(7):e69325. doi: 10.1371/journal.pone.0069325.
   PubMed Web of Science ®Google Scholar
• Blanco-Aparicio C, Molina MA, Fernández-Salas E, et al. Potato carboxypeptidase inhibitor, a T-knot protein, is an epidermal growth factor antagonist that inhibits tumor cell growth. J Biol Chem. 1998;273(20):12370–12377. doi: 10.1074/jbc.273.20.12370.
   PubMed Web of Science ®Google Scholar
• Sitjà-Arnau M, Molina MA, Blanco-Aparicio C, et al. Mechanism of action of potato carboxypeptidase inhibitor (PCI) as an EGF blocker. Cancer Lett. 2005;226(2):169–184. doi: 10.1016/j.canlet.2005.01.025.
   PubMed Web of Science ®Google Scholar
• Carrión-Salip D, Panosa C, Menendez JA, et al. Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands. Int J Oncol. 2012;41(3):1128–1138. doi: 10.3892/ijo.2012.1509.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Sakamoto S. Radioimmunoassay of human epidermal growth factor–hEGF levels in human body fluids. J Pharmacobiodyn. 1988;11(3):146–151. doi: 10.1248/bpb1978.11.146.
   PubMedGoogle Scholar
• Kivisaari AK, Kallajoki M, Ala-Aho R, et al. Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma. Br J Dermatol. 2010;163(4):726–735. doi: 10.1111/j.1365-2133.2010.09924.x.
   PubMed Web of Science ®Google Scholar
• Van Doorn R, Kirtschig G, Scheffer E, et al. Follicular and epidermal alterations in patients treated with ZD1839 (iressa), an inhibitor of the epidermal growth factor receptor. Br J Dermatol. 2002;147(3):598–601. doi: 10.1046/j.1365-2133.2002.04864.x.
   PubMed Web of Science ®Google Scholar
• Amagai M, Ozawa S, Ueda M, et al. Distribution of EGF receptor expressing and DNA replicating epidermal cells in psoriasis vulgaris and bowen’s disease. Br J Dermatol. 1988;119(5):661–668. doi: 10.1111/j.1365-2133.1988.tb03480.x.
   PubMed Web of Science ®Google Scholar